asarum_europaeum_l
Unterschiede
Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen RevisionVorhergehende Überarbeitung | |||
asarum_europaeum_l [2016/07/10 14:40] – andreas | asarum_europaeum_l [2017/01/02 16:57] (aktuell) – andreas | ||
---|---|---|---|
Zeile 21: | Zeile 21: | ||
[Hagers Handbuch der Pharmazeutischen Praxis, Springer 2010] | [Hagers Handbuch der Pharmazeutischen Praxis, Springer 2010] | ||
- | In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with approximately | + | In 2010, the use of all plants belonging to the Asarum species in drugs was banned in Germany by decree of the Federal Institute for Drugs and Medical Devices (BfArM). The cause of this was the detection of aristolochic acid I in homeopathic mother tinctures of Asarum europaeum with 3.8-85.0 μg/kg (0.044-0.085 ppm), and of Asarum canadense with approximately 127.4µg/kg (about 0.13 ppm). \\ |
[[http:// | [[http:// | ||
asarum_europaeum_l.1468161605.txt.gz · Zuletzt geändert: 2016/07/10 14:40 von andreas